Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.
about
Bacterial charity work leads to population-wide resistanceSublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesisThe development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins.Correlation between virulence genotype and fluoroquinolone resistance in carbapenem-resistant Pseudomonas aeruginosa.Multidrug-resistant Pseudomonas aeruginosa strain that caused an outbreak in a neurosurgery ward and its aac(6')-Iae gene cassette encoding a novel aminoglycoside acetyltransferase.Detection of ciprofloxacin-resistant Yersinia pestis by fluorogenic PCR using the LightCycler.Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.Efflux-mediated resistance to fluoroquinolones in gram-negative bacteriaMutant selection window and characterization of allelic diversity for ciprofloxacin-resistant mutants of Rhodococcus equi.Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa.Type II and type IV topoisomerase mutations in clinical isolates of Morganella morganii harbouring the qnrD gene.The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibilityAntibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacinOutbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan.A Carbapenem-Resistant Pseudomonas aeruginosa Isolate Harboring Two Copies of blaIMP-34 Encoding a Metallo-β-Lactamase.Clinical and Molecular Epidemiology of Multidrug-Resistant P. aeruginosa Carrying aac(6')-Ib-cr, qnrS1 and blaSPM Genes in Brazil.Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.Fitness Cost of Fluoroquinolone Resistance in Clinical Isolates of Pseudomonas aeruginosa Differs by Type III Secretion Genotype.Reactive oxygen species drive evolution of pro-biofilm variants in pathogens by modulating cyclic-di-GMP levels.Comparative genome analysis of ciprofloxacin-resistant Pseudomonas aeruginosa reveals genes within newly identified high variability regions associated with drug resistance development.Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence.The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.Effects of rice seed surface sterilization with hypochlorite on inoculated Burkholderia vietnamiensis.Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae, A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance.Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility.Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone.Antibacterial Resistance in Ureaplasma species and Mycoplasma hominis Isolates from Urine Cultures in College-aged Females.Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance.Spontaneous quinolone resistance in the zoonotic serovar of Vibrio vulnificus.Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa.Carrion's Disease: the Sound of Silence.Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam.Quinolone-resistant clinical strains of Pseudomonas aeruginosa isolated from University Hospital in Tunisia.
P2860
Q24613731-0FE3F31C-E173-428A-9664-1E47C05D1314Q24625342-B0B4D7FC-28C1-4E73-9B72-7370FF918453Q33653162-013C85AC-BA4B-424C-808F-4CCC838FB636Q33807598-ABE4A3B3-2C55-4BCC-B153-4A430C64B131Q33935293-BBB49807-29B0-4901-A1D5-4A6B91F9BB24Q33973670-CFA29984-0AC6-4C34-B3BA-C7F1AFEEBFEAQ33982709-E341B84A-8D2E-4657-B5FB-B15A10D645AFQ34010692-7BAC8829-09B9-415E-A196-F19C9259D5CDQ34045286-7B06F41A-8D9C-428D-BCED-22133676934EQ34384649-D46EBFBA-0BB1-4F70-9B2F-31F33C8FE079Q34538010-D9FEDDEF-AACB-474B-A270-1FB2B06AC124Q34922676-9297E126-DE2E-4B02-8ECF-807A876532A5Q35007624-962E988D-0895-46E5-8D17-3B3418EFBF79Q35598576-4ED6CCC6-3E7B-403E-A87F-FF52AAFECDC9Q35690703-64520403-B027-4101-AFAE-CCCF81B3C807Q35982821-08CF4897-E145-4755-9CA4-3995C464C04CQ36027868-2B5CC9FD-250A-48DC-A6F0-3219C59F829FQ37190771-F11B17F0-5C31-4B08-98B6-A11AB08EC87CQ37306380-E5660322-F44A-4DA8-874F-92DB13B57C40Q37464130-521E222D-30B4-4FD1-901F-3F45532270D9Q37469236-7B5BAB6C-FEF9-4AA7-985D-697A5BBD9A35Q37643058-3CA40212-BCC7-416A-A6A2-2D6C44A0327BQ39310402-A0074CEB-5CF9-46D3-B09A-1F66065B3E4CQ39491585-12CB9EC0-594E-4C6C-B810-575E2FCAB61FQ39651132-EE1CB97B-9B80-497D-951E-957CD4A3F8C8Q39652979-0BFA2013-E83E-473D-AE7E-2DE93D520925Q39755440-A48FACC2-522E-4ECC-B462-5DE4F7110228Q40085140-FE7F7467-1C30-4123-B754-EC024C5432BAQ41454301-55AF070D-1564-4CB5-B62F-1DF34D3DA75FQ41901241-3A42FA30-78F3-4FC6-B63B-28A3CFF107C0Q42910111-70408CAF-36F2-493E-81E0-408143450C8BQ46251748-E31BBB42-2F49-4DCA-A9BC-CC965C933090Q53702253-72AAF200-B9E1-46A2-B5C3-531CD3B29B49Q53716911-2DE21181-9AEB-4BC2-9A37-6AF32E68018A
P2860
Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Type II topoisomerase mutation ...... ins of Pseudomonas aeruginosa.
@ast
Type II topoisomerase mutation ...... ins of Pseudomonas aeruginosa.
@en
type
label
Type II topoisomerase mutation ...... ins of Pseudomonas aeruginosa.
@ast
Type II topoisomerase mutation ...... ins of Pseudomonas aeruginosa.
@en
prefLabel
Type II topoisomerase mutation ...... ins of Pseudomonas aeruginosa.
@ast
Type II topoisomerase mutation ...... ins of Pseudomonas aeruginosa.
@en
P2093
P2860
P356
P1476
Type II topoisomerase mutation ...... ains of Pseudomonas aeruginosa
@en
P2093
P2860
P356
10.1128/AAC.43.1.62
P407
P577
1999-01-01T00:00:00Z